VivoSim to Carry Forward Organovo 3D Bioprinting

Written by Emily J. Thompson, Senior Investment Analyst

ONVO%

Source: Newsfilter

Updated: Apr 23 2025

0mins

Source: Newsfilter

Company Name Change: Organovo Holdings, Inc. will officially change its name to VivoSim Labs, Inc. on April 24, 2025, with its common stock trading under the new ticker symbol "VIVS" on the Nasdaq Capital Market.
Forward-Looking Statements Disclaimer: The company issued a caution regarding forward-looking statements, highlighting that these are based on current expectations and subject to various risks and uncertainties as detailed in their SEC filings.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

VivoSim to Carry Forward Organovo 3D Bioprinting

About the author

Top News

Oil Firms Cautious on Venezuela Investment Push

GM Reports $7.1 Billion Charge Amid EV Shift

Stock Market Wraps 2025 with Double-Digit Gains

Novo Nordisk's Weight-Loss Pill Approval: Key Impacts

Related Articles

Chipotle vs Dutch Bros: Growth vs Valuation Showdown

XRP Drops 40% from July Peak; Ripple's Products Face Adoption Challenges

Sigh Up to Get Intellectia Insights

How did the company's recent strategic decisions impact its latest financial performance?

Can you explain the factors behind the recent changes in the company's stock price?

What are the expected impacts of current market trends on the company's future growth?

Based on the latest earnings report, what are the company's forecasted revenues for the next quarter?

How does the company's performance compare to its main competitors in the same sector?

People Also Watch